医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mannatech Hong Kong Office Grand Opening Set for August 8

2016年08月05日 AM10:00
このエントリーをはてなブックマークに追加


 

HONG KONG

Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, will hold a grand opening event for its Hong Kong office on Monday, August 8, from 10 a.m. to 12 p.m. at Lippo Sun Plaza, Unit 1501, 15th Floor, 28 Canton Road, Tsim Sha Tsui, Kowloon, Hong Kong.

Mannatech’s Hong Kong office grand opening will have a number of special guests including the company’s CEO and President, Alfredo “Al” Bala, Mannatech’s Regional President of Asia, Patrick Park, and company co-founder and member of the Board of Directors, Ray Robbins.

The new office will be the business hub for Mannatech’s activities in the Hong Kong region. It has been designed to facilitate and support Mannatech’s independent sales Associates’ activities as well as holding meetings and training sessions.

“This is an exciting time for Mannatech in Hong Kong as we officially welcome our Associates to their new home for business,” said Mannatech Hong Kong’s General Manager Roger Hsueh. “Mannatech has been steadily building its presence in Hong Kong for some time and this office opening is key to regional growth and for providing proactive support to our independent sales Associates who are building strong, long-term businesses here.”

The grand opening ceremony will include addresses by Park, Bala, Robbins and Hsueh, as well as a ribbon cutting and entertainment provided by a lion dance troupe. Attendees to the event will be treated our TruPlenish shakes, tours of the office and will be able to talk to top Mannatech corporate and field sales leaders.

Mannatech Hong Kong Associates are welcome to attend as well as interested members of the public.

To begin transforming your life or the lives of those around you, please visit Mannatech.com.

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience through a financially rewarding opportunity that makes a difference in the lives of people across the world. Through its innovative glyconutrition products, Mannatech transforms lives, providing an unprecedented level of natural wellness, freedom and purpose.* With more than 20 years of experience and operations in more than 25 countries, Mannatech is committed to transforming lives. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160804005907/en/

CONTACT

Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245
pr@mannatech.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • DSG, Inc. Accelerates Growth with Opening of New Office in Bangalore, India
  • 仁和集团与APR应用制药研究公司公布协议在中国市场销售治疗偏头痛创新药
  • 武田连续第二年入选全球可持续发展最佳企业百强榜单
  • InFo 124M – 瑞士生产的用于白内障手术的延伸焦深人工晶体
  • 2017 Taiwan WHO Simulation Kicks off at NCKU with 240 Medical Students Sharing